Literature DB >> 23341447

β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Anne O Watts1, Folkert Verkaar, Miranda M C van der Lee, Claudia A W Timmerman, Martien Kuijer, Jody van Offenbeek, Lambertus H C J van Lith, Martine J Smit, Rob Leurs, Guido J R Zaman, Henry F Vischer.   

Abstract

Chemokine receptors form a large subfamily of G protein-coupled receptors that predominantly activate heterotrimeric Gi proteins and are involved in immune cell migration. CCX-CKR is an atypical chemokine receptor with high affinity for CCL19, CCL21, and CCL25 chemokines, but is not known to activate intracellular signaling pathways. However, CCX-CKR acts as decoy receptor and efficiently internalizes these chemokines, thereby preventing their interaction with other chemokine receptors, like CCR7 and CCR9. Internalization of fluorescently labeled CCL19 correlated with β-arrestin2-GFP translocation. Moreover, recruitment of β-arrestins to CCX-CKR in response to CCL19, CCL21, and CCL25 was demonstrated using enzyme-fragment complementation and bioluminescence resonance energy transfer methods. To unravel why CCX-CKR is unable to activate Gi signaling, CCX-CKR chimeras were constructed by substituting its intracellular loops with the corresponding CCR7 or CCR9 domains. The signaling properties of chimeric CCX-CKR receptors were characterized using a cAMP-responsive element (CRE)-driven reporter gene assay. Unexpectedly, wild type CCX-CKR and a subset of the chimeras induced an increase in CRE activity in response to CCL19, CCL21, and CCL25 in the presence of the Gi inhibitor pertussis toxin. CCX-CKR signaling to CRE required an intact DRY motif. These data suggest that inactive Gi proteins impair CCX-CKR signaling most likely by hindering the interaction of this receptor with pertussis toxin-insensitive G proteins that transduce signaling to CRE. On the other hand, recruitment of the putative signaling scaffold β-arrestin to CCX-CKR in response to chemokines might allow activation of yet to be identified signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23341447      PMCID: PMC3591626          DOI: 10.1074/jbc.M112.406108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization.

Authors:  M Blomenröhr; A Heding; R Sellar; R Leurs; J Bogerd; K A Eidne; G B Willars
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

Review 2.  Mammalian G proteins and their cell type specific functions.

Authors:  Nina Wettschureck; Stefan Offermanns
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

3.  Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor.

Authors:  Takeshi Maruko; Tsutomu Nakahara; Kenji Sakamoto; Maki Saito; Naotoshi Sugimoto; Yoh Takuwa; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

4.  Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR.

Authors:  Jane R Townson; Robert J B Nibbs
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

Review 5.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

6.  Cloning of CCRL1, an orphan seven transmembrane receptor related to chemokine receptors, expressed abundantly in the heart.

Authors:  H Khoja; G Wang; C T Ng; J Tucker; T Brown; V Shyamala
Journal:  Gene       Date:  2000-04-04       Impact factor: 3.688

7.  beta-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6.

Authors:  Emanuela Galliera; Venkatakrishna R Jala; John O Trent; Raffaella Bonecchi; Paola Signorelli; Robert J Lefkowitz; Alberto Mantovani; Massimo Locati; Bodduluri Haribabu
Journal:  J Biol Chem       Date:  2004-04-13       Impact factor: 5.157

8.  Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.

Authors:  D S Bahia; A Wise; F Fanelli; M Lee; S Rees; G Milligan
Journal:  Biochemistry       Date:  1998-08-18       Impact factor: 3.162

9.  Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes.

Authors:  R G Vickery; M von Zastrow
Journal:  J Cell Biol       Date:  1999-01-11       Impact factor: 10.539

10.  Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine.

Authors:  Oliver Pabst; Lars Ohl; Meike Wendland; Marc-André Wurbel; Elisabeth Kremmer; Bernard Malissen; Reinhold Förster
Journal:  J Exp Med       Date:  2004-01-26       Impact factor: 14.307

View more
  17 in total

1.  Transient expression of recombinant ACKR4 (CCRL1) gene, an atypical chemokine receptor in human embryonic kidney (HEK 293) cells.

Authors:  Bahareh Parsi; Abolghasem Esmaeili; Mohammad Hashemi; Mohaddeseh Behjati
Journal:  Mol Biol Rep       Date:  2016-05-11       Impact factor: 2.316

2.  Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Authors:  Guido J R Zaman; Martine J Smit; Folkert Verkaar; Jody van Offenbeek; Miranda M C van der Lee; Lambertus H C J van Lith; Anne O Watts; Angelique L W M M Rops; David C Aguilar; Joshua J Ziarek; Johan van der Vlag; Tracy M Handel; Brian F Volkman; Amanda E I Proudfoot; Henry F Vischer
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses.

Authors:  Mette M Rosenkilde; Naotaka Tsutsumi; Julius M Knerr; Dagmar F Kildedal; K Christopher Garcia
Journal:  Annu Rev Virol       Date:  2022-06-07       Impact factor: 14.263

5.  Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma.

Authors:  Jie-Yi Shi; Meng Duan; Qi-Man Sun; Liuxiao Yang; Zhi-Chao Wang; Ospan A Mynbaev; Yi-Feng He; Ling-Yan Wang; Jian Zhou; Qi-Qun Tang; Ya Cao; Jia Fan; Xiao-Ying Wang; Qiang Gao
Journal:  Tumour Biol       Date:  2016-01-26

Review 6.  Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis.

Authors:  Jinjung Choi; Carlo Selmi; Patrick S C Leung; Thomas P Kenny; Tania Roskams; M Eric Gershwin
Journal:  Expert Rev Clin Immunol       Date:  2016-02-25       Impact factor: 4.473

Review 7.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

Review 8.  Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.

Authors:  Sabrina M de Munnik; Martine J Smit; Rob Leurs; Henry F Vischer
Journal:  Front Pharmacol       Date:  2015-03-09       Impact factor: 5.810

9.  The Viral G Protein-Coupled Receptor ORF74 Hijacks β-Arrestins for Endocytic Trafficking in Response to Human Chemokines.

Authors:  Sabrina M de Munnik; Albert J Kooistra; Jody van Offenbeek; Saskia Nijmeijer; Chris de Graaf; Martine J Smit; Rob Leurs; Henry F Vischer
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

10.  New nomenclature for atypical chemokine receptors.

Authors:  Françoise Bachelerie; Gerard J Graham; Massimo Locati; Alberto Mantovani; Philip M Murphy; Robert Nibbs; Antal Rot; Silvano Sozzani; Marcus Thelen
Journal:  Nat Immunol       Date:  2014-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.